CPhI South Korea Korea positioned to be global biopharma powerhouse, says industry association 25-Aug-2016 By Dan Stanton Stem cells and biosimilars are driving the Korean pharma market, according to the country’s Biomedicine Industry Association KoBIA.
Biologic makers looking to delivery devices to gain competitive edge, Bespak 05-Jan-2016 By Dan Stanton Having a proactive approach to delivery technologies will give pharma firms a competitive edge against biosimilars and biobetters, according to device maker Bespak.